Insight Molecular Diagnostics (IMDX) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Insight Molecular Diagnostics is the larger company by market cap ($107.3 million vs $6.6 million), about 16.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | VNRX |
|---|---|---|
| Share price | $3.28 | $0.2194 |
| Market cap | $107.34M | $6.60M |
| 1-day change | -5.20% | -2.92% |
| YTD return | -56.27% | — |
| 1-year return | -10.87% | — |
| 5-year return | -95.18% | — |
| EPS (TTM) | $-1.52 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $10.40 |
| 52-week low | $2.42 | $0.217 |
| Distance from 52-week high | -61.46% | -97.89% |
| Analyst consensus | none | none |
| Avg. price target upside | +151.52% | +6107.84% |
| Average volume | 232.87K | 8.47M |
| Shares outstanding | 32.72M | 30.06M |
| Employees | 55 | 57 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Insight Molecular Diagnostics is about 16.3 times larger than VolitionRX by market value ($107.34M vs $6.60M).
About Insight Molecular Diagnostics
IMDX stock →Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
Healthcare · Diagnostics & Research · 55 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Healthcare · Medical Devices · 57 employees
IMDX vs VNRX FAQ
Which is bigger, Insight Molecular Diagnostics or VolitionRX?
Insight Molecular Diagnostics (IMDX) is larger, with a market capitalization of $107.34M compared with $6.60M for VolitionRX (VNRX).
Are Insight Molecular Diagnostics and VolitionRX in the same industry?
Both are in the Healthcare sector, but in different industries: Diagnostics & Research for Insight Molecular Diagnostics and Medical Devices for VolitionRX.